Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 171

1.

Mutations in the human cytomegalovirus UL27 gene that confer resistance to maribavir.

Chou S, Marousek GI, Senters AE, Davis MG, Biron KK.

J Virol. 2004 Jul;78(13):7124-30.

PMID:
15194788
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Diverse cytomegalovirus UL27 mutations adapt to loss of viral UL97 kinase activity under maribavir.

Chou S.

Antimicrob Agents Chemother. 2009 Jan;53(1):81-5. doi: 10.1128/AAC.01177-08. Epub 2008 Nov 3.

PMID:
18981262
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Effects on maribavir susceptibility of cytomegalovirus UL97 kinase ATP binding region mutations detected after drug exposure in vitro and in vivo.

Chou S, Hakki M, Villano S.

Antiviral Res. 2012 Aug;95(2):88-92. doi: 10.1016/j.antiviral.2012.05.013. Epub 2012 Jun 1.

PMID:
22664236
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Cytomegalovirus UL97 kinase mutations that confer maribavir resistance.

Chou S, Wechel LC, Marousek GI.

J Infect Dis. 2007 Jul 1;196(1):91-4. Epub 2007 May 17.

PMID:
17538888
[PubMed - indexed for MEDLINE]
Free Article
5.

Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir.

Chou S.

Rev Med Virol. 2008 Jul-Aug;18(4):233-46. doi: 10.1002/rmv.574. Review.

PMID:
18383425
[PubMed - indexed for MEDLINE]
6.

Conserved domains and structure prediction of human cytomegalovirus UL27 protein.

Hantz S, Couvreux A, Champier G, Trapes L, Cotin S, Denis F, Bouaziz S, Alain S.

Antivir Ther. 2009;14(5):663-72.

PMID:
19704169
[PubMed - indexed for MEDLINE]
7.

Resistance of human cytomegalovirus to the benzimidazole L-ribonucleoside maribavir maps to UL27.

Komazin G, Ptak RG, Emmer BT, Townsend LB, Drach JC.

J Virol. 2003 Nov;77(21):11499-506.

PMID:
14557635
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Accelerated evolution of maribavir resistance in a cytomegalovirus exonuclease domain II mutant.

Chou S, Marousek GI.

J Virol. 2008 Jan;82(1):246-53. Epub 2007 Oct 17.

PMID:
17942550
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Cytomegalovirus UL97 phosphotransferase mutations that affect susceptibility to ganciclovir.

Chou S, Waldemer RH, Senters AE, Michels KS, Kemble GW, Miner RC, Drew WL.

J Infect Dis. 2002 Jan 15;185(2):162-9. Epub 2001 Dec 17.

PMID:
11807689
[PubMed - indexed for MEDLINE]
Free Article
10.

Genotypic characterization of human cytomegalovirus UL97 phosphotransferase natural polymorphism in the era of ganciclovir and maribavir.

Boutolleau D, Burrel S, Agut H.

Antiviral Res. 2011 Jul;91(1):32-5. doi: 10.1016/j.antiviral.2011.04.015. Epub 2011 May 4.

PMID:
21570426
[PubMed - indexed for MEDLINE]
11.

Cyclopropavir inhibits the normal function of the human cytomegalovirus UL97 kinase.

James SH, Hartline CB, Harden EA, Driebe EM, Schupp JM, Engelthaler DM, Keim PS, Bowlin TL, Kern ER, Prichard MN.

Antimicrob Agents Chemother. 2011 Oct;55(10):4682-91. doi: 10.1128/AAC.00571-11. Epub 2011 Jul 25.

PMID:
21788463
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Conserved retinoblastoma protein-binding motif in human cytomegalovirus UL97 kinase minimally impacts viral replication but affects susceptibility to maribavir.

Gill RB, Frederick SL, Hartline CB, Chou S, Prichard MN.

Virol J. 2009 Jan 21;6:9. doi: 10.1186/1743-422X-6-9.

PMID:
19159461
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Resistance to maribavir is associated with the exclusion of pUL27 from nucleoli during human cytomegalovirus infection.

Hakki M, Drummond C, Houser B, Marousek G, Chou S.

Antiviral Res. 2011 Nov;92(2):313-8. doi: 10.1016/j.antiviral.2011.08.019. Epub 2011 Sep 1.

PMID:
21906628
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Expression of the human cytomegalovirus UL97 gene in a chimeric guinea pig cytomegalovirus (GPCMV) results in viable virus with increased susceptibility to ganciclovir and maribavir.

McGregor A, Choi KY, Cui X, McVoy MA, Schleiss MR.

Antiviral Res. 2008 Jun;78(3):250-9. doi: 10.1016/j.antiviral.2008.01.008. Epub 2008 Feb 14.

PMID:
18325607
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Cytomegalovirus UL97 kinase catalytic domain mutations that confer multidrug resistance.

Chou S, Ercolani RJ, Marousek G, Bowlin TL.

Antimicrob Agents Chemother. 2013 Jul;57(7):3375-9. doi: 10.1128/AAC.00511-13. Epub 2013 May 6.

PMID:
23650173
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Phenotyping of cytomegalovirus drug resistance mutations by using recombinant viruses incorporating a reporter gene.

Chou S, Van Wechel LC, Lichy HM, Marousek GI.

Antimicrob Agents Chemother. 2005 Jul;49(7):2710-5.

PMID:
15980340
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Rapid semiquantitative real-time PCR for the detection of human cytomegalovirus UL97 mutations conferring ganciclovir resistance.

Göhring K, Mikeler E, Jahn G, Rohde F, Hamprecht K.

Antivir Ther. 2008;13(3):461-6.

PMID:
18572760
[PubMed - indexed for MEDLINE]
18.

Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet.

Drew WL, Miner RC, Marousek GI, Chou S.

J Clin Virol. 2006 Oct;37(2):124-7. Epub 2006 Sep 8.

PMID:
16962820
[PubMed - indexed for MEDLINE]
19.

Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina.

Sánchez Puch S, Ochoa C, Carballal G, Zala C, Cahn P, Brunet R, Salomón H, Videla C.

J Clin Virol. 2004 Jul;30(3):271-5.

PMID:
15135748
[PubMed - indexed for MEDLINE]
20.

Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action.

Biron KK, Harvey RJ, Chamberlain SC, Good SS, Smith AA 3rd, Davis MG, Talarico CL, Miller WH, Ferris R, Dornsife RE, Stanat SC, Drach JC, Townsend LB, Koszalka GW.

Antimicrob Agents Chemother. 2002 Aug;46(8):2365-72.

PMID:
12121906
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk